Renatech Inc. (Headquarters: Isehara City, Kanagawa Prefecture), a company that develops health indicators based on trace elements and applies them to real-world use, announces the opening of reservations for its self-developed and provided screening test, the 'Metallo-Balance Test,' which evaluates the risk of cancer and MCI (mild cognitive impairment). Reservations are now open for testing on Sunday, September 27, 2026, and Sunday, November 15, 2026, at its partner medical institution, Tsukuba Gastroenterology & Endoscopy Clinic (Tsukuba City, Ibaraki Prefecture).

With the establishment of a continuous testing system at this clinic, access to the 'Metallo-Balance Test' in Tsukuba City will be stably secured, contributing as a convenient option for local residents' daily health management and pre-disease care.

Renatech will continue to maintain and expand its nationwide network of partner medical institutions, aiming to encourage more people to take interest in their health and reflect on their daily habits and lifestyle as part of pre-disease prevention.

What is the Metallo-Balance (MB) Test?

The Metallo-Balance Test is a risk screening (triage) test that objectively evaluates the risk of cancer and MCI (mild cognitive impairment) at the time of blood draw by analyzing the concentration balance of 17 trace elements (metal elements) in the blood.

【Features of the Test】

Only one 6mL blood draw: Blood is safely collected under proper medical supervision. The test takes approximately 15 minutes, minimizing physical burden and ensuring safety.

Site-specific 'Cancer Risk Test': With a single blood draw, cancer risk is evaluated by body site (6 sites for men, 9 for women) and scored on a four-tier scale from A to D. [Men] Lung cancer, stomach cancer, liver cancer, pancreatic cancer, colorectal cancer, prostate cancer [Women] Lung cancer, stomach cancer, liver cancer, pancreatic cancer, colorectal cancer, breast cancer, cervical cancer, endometrial cancer, ovarian cancer

Comprehensive 'Cognitive Risk Test (MCI Risk Assessment)': Evaluates all types of MCI, including Alzheimer's type, vascular type, and Lewy body type.

Proven research results and international recognition: Developed through joint research with Kanagawa Prefectural Cancer Center and Chiba Prefectural Cancer Center, supported by a research grant from the Ministry of Economy, Trade and Industry's Go-Tech program. Patented in 9 countries including Japan, with over 100,000 test-takers cumulatively (from April 2019 to March 2026).

Testing Procedure and Key Pre-Test Instructions

※ Due to the need for document mailing, advance registration is required approximately 3 weeks before the desired test date (by the deadline, under a full reservation system).

Registration: Register via the website or by phone. A complete set of test documents will be delivered to your home about one week before your appointment.

Test Day (Blood Draw): As the clinic operates on a full reservation basis, blood collection will proceed smoothly (takes about 15 minutes). Payment is on a post-payment basis, so there is no need to settle fees at the clinic on the day.

Results Notification: Your invoice (payment slip) will be mailed to your home approximately 3 weeks after blood draw, and your test results will be sent approximately 5 weeks later.

【Key Pre-Test Instructions】

Food and Alcohol: No food after 9 PM the previous day. No alcohol consumption the day before. Hydration: Drink plenty of water to make blood draw easier.

Medications and Supplements: Over-the-counter medicines and supplements should not be taken the day before. Prescription medications may be taken as usual.

Test Fees (Private Pay)

This test is a private-pay service not covered by health insurance. Choose from the following plans based on your needs:

Cancer Risk Test: ¥19,800 (tax included)

Cognitive Risk Test: ¥19,800 (tax included)

Cancer and Cognitive Risk Test (Combo): ¥24,200 (tax included)

※ Listed prices are standard prices. ※ Payment will be made via 'DSK Postpay,' delivered to your home after blood draw. ※ Some medical institutions may not offer one of the tests.

Eligibility and Important Notes for the Metallo-Balance Test

【Age Eligibility】

Cancer Risk Test: Japanese nationals aged 20 to 80

Cognitive Risk Test: Japanese nationals aged 50 to 80

※ The test was developed based on data from Japanese individuals within the above age ranges. While individuals outside these age groups or foreign nationals may take the test, results will be considered 'for reference only.' Please understand this in advance.

【Individuals Who Cannot Take the Test】

Pregnant individuals or those who have given birth within the last 6 months

Individuals currently undergoing cancer treatment, or who completed treatment less than 1 year ago

Individuals receiving dialysis

Individuals with fractures, blood disorders, or immunodeficiency (excluding lipid abnormalities such as high triglycerides)

Individuals feeling unwell (due to lack of sleep, after an all-nighter, immediately after intense exercise, under high stress, or with symptoms such as cold, asthma, shingles, allergic rash, or rhinitis)

Overview of Partner Medical Institution

Test Schedule: Generally the 3rd Sunday of every other month (excluding holidays and clinic closure days)

Medical Institution Name: Tsukuba Gastroenterology & Endoscopy Clinic

Address: 3F Tsukuba Clinic Center Building, 3-1-1 Kasuga, Tsukuba City, Ibaraki 305-0821 🅿️ Parking available 📍MAP

Available Tests: Cancer Risk Test and Cognitive Risk Test

▼ Check Available Dates and Make a Reservation

The testing schedules for September and November, as well as the latest schedule from January 2027 onward, can be viewed and booked at any time via the following web reservation system:

Metallo-Balance Test Web Reservation: https://metallo-balance.net/entry/

<Steps to Check Dates and Apply>

On the above URL, select 'General Public' (red button)

Under 'Search for Test Venue,' select the region (Kanto > Ibaraki Prefecture)

Select 'Tsukuba Gastroenterology & Endoscopy Clinic' as the test venue to view currently available testing dates. ※ Each testing slot has a limited capacity. Registration will close once full, so please understand in advance.

⚠️ Important Notice Regarding Testing (Please Read Carefully) Please refrain from contacting the medical institution directly: The hospital front desk or phone line cannot handle inquiries or reservations for this test. All inquiries and applications regarding the test should be directed to Renatech.

For more details and to apply:

Metallo-Balance Test Information Site (for full details): https://www.mbkensa.com/

Toll-Free Number: 0120-785-602 (Renatech: Weekdays 9:00–17:00)

▼ Digital Version of Metallo-Balance Test Brochure

d182526-30-980fbb8b56aae52c08dc38fd4bd4e32b.pdf

🏥 Partner medical institutions nationwide are also being recruited! For information on introducing the Metallo-Balance Test, please visit:

Metallo-Balance Original Character: Metalona-chan

Renatech Inc. is an innovative company developing proprietary technologies in the medical, health, and environmental fields, aiming to enable early risk assessment of diseases such as cancer. It has been selected as one of the '300 Outstanding SMEs and Small Businesses' by the Ministry of Economy, Trade and Industry and the Small and Medium Enterprise Agency, recognizing its high technological capability and social contribution.

Among its offerings, the 'Metallo-Balance Test'

FACT BOX

  • Source: PR TIMES
  • Category: Partnership